Based on 39 sources
Found 39 search sources
JN.1, the Dominant Variant in the COVID Surge | Johns Hopkins ...COVID-19 Variant UpdateETF recommends updating COVID-19 vaccines to target new JN.1 ...3 Things to Know About JN.1, the New Coronavirus Strain > News ...COVID-19 Variant JN.1: Symptoms, Severity and TreatmentJN.1 variant makes up a majority of COVID cases in the US. Here's ...新冠肺炎增258例！新變異株JN.1占本土3% 恐傳播疫情升溫COVID-19 Activity Increases as Prevalence of JN.1 Variant ...Update on SARS-CoV-2 Variant JN.1 Being Tracked by CDC | NCIRDCOVID-19: WHO designates JN.1 'variant of interest' amid sharp rise ...JN.1 as a new variant of COVID-19 - editorialWhat to Know About the New COVID-19 Variant JN.1 | Health News ...COVID variant JN.1 now more than 90% of cases in U.S., CDC ...COVID-19 Variant JN.1 is on the Rise. Here's What to Know. | Novel ...COVID-19 Variant JN.1 is on the Rise. Here's What to Know. | UC ...New COVID Variant JN.1 Could Disrupt Holiday PlansCOVID and flu surge could strain hospitals as JN.1 variant grows ...JN.1 Omicron subvariant: Questions patients may have | American ...The JN.1 COVID Variant: Symptoms, Incubation Period and When to ...JN.1 COVID Variant Symptoms vs. Allergy SymptomsCovid-19 variant JN.1 is now the leading cause of infections in the ...Covid symptoms caused by JN.1 variant: What to know as cases riseGlobal spread of COVID-19's JN.1 variant: Implications and public ...What Is JN.1, the Latest COVID Variant? | The Transmission ...What to Know About the JN.1 Variant of the COVID-19 VirusJN.1 variant in enduring COVID-19 pandemic: is it a variety of ...Emergence and spread of JN.1 COVID-19 variant | Bulletin of the ...WHO COVID vaccine advisers recommend switch to JN.1 strain ...Effectiveness of the 2023-2024 Formulation of the Coronavirus ...Will COVID Vaccines Continue to Work Against JN.1 and Other New ...COVID-19 Vaccine Effectiveness | NCIRD | CDCEarly Estimates of Updated 2023–2024 (Monovalent XBB.1.5 ...Virological characteristics of the SARS-CoV-2 JN.1 variant - The ...Virological characteristics of the SARS-CoV-2 JN.1 variant | bioRxiv1 Executive Summary Initial Risk Evaluation of JN.1, 19 December ...Comparison of Clinical Characteristics of Children Infected With ...SARS-CoV-2 Variant Classifications and DefinitionsJN.1 Lineage ReportUnderstanding the virological properties of SARS-CoV-2 variant JN.1
JN.1, the Dominant Variant in the COVID Surge | Johns Hopkins ...Jan 9, 2024 ... What does the transmission timeline look like for JN.1? The period of infectiousness for JN. ... After exposure, it may take five days or more ...
COVID-19 Variant UpdateAs of June 11, 2024, the SARS-CoV-2 Omicron variants JN.1 and JN.1 descendants KP.2 and KP.3 have high prevalence in the United States.
ETF recommends updating COVID-19 vaccines to target new JN.1 ...Apr 30, 2024 ... Updated vaccines will help maintain protection against disease as virus continues to evolve. NewsHumanCOVID-19Vaccines ...
3 Things to Know About JN.1, the New Coronavirus Strain > News ...Jan 31, 2024 ... The virus that causes COVID-19 has continued to mutate and spread. A new strain, JN.1, may be highly transmissible. Yale experts tell you ...
COVID-19 Variant JN.1: Symptoms, Severity and TreatmentFeb 2, 2024 ... Common symptoms reported include sore throat, nausea, and diarrhea within a few days of the illness' onset. Loss of smell may be less frequently ...
JN.1 variant makes up a majority of COVID cases in the US. Here's ...Jan 5, 2024 ... 1 variant makes up a majority of COVID cases in the US. Here's what to know ... JN.1 makes up an estimated 61.6% of COVID cases, CDC data shows.
新冠肺炎增258例！新變異株JN.1占本土3% 恐傳播疫情升溫變異株JN.1具免疫脫逃性疫情傳播升溫. Yahoo奇摩（即時新聞）. 2023年12月19日. 衛福部疾管署今天公布國內12日至18日新增258例新冠肺炎本土確定病例（併發症），較前 ...
COVID-19 Activity Increases as Prevalence of JN.1 Variant ...Jan 5, 2024 ... Based on current data, available vaccines, tests, and treatments work against JN.1. What CDC is doing. CDC, in collaboration with state and ...
Update on SARS-CoV-2 Variant JN.1 Being Tracked by CDC | NCIRDDec 8, 2023 ... Summary. What CDC knows. JN.1, a variant of the virus that causes COVID-19, is a closely related offshoot of ...
COVID-19: WHO designates JN.1 'variant of interest' amid sharp rise ...Dec 20, 2023 ... The UN World Health Organization (WHO) has said it is continuously monitoring the global spread of JN.1, a COVID-19 variant of interest, ...
JN.1 as a new variant of COVID-19 - editorialJN.1 as a new variant of COVID-19 - editorial. Ann Med Surg (Lond). 2024 Feb 28;86(4):1833-1835. doi: 10.1097/MS9.0000000000001876. eCollection 2024 Apr.
What to Know About the New COVID-19 Variant JN.1 | Health News ...Dec 14, 2023 ... JN.1 is the fastest growing variant in the U.S., making up more than 1 in 5 new coronavirus infections, according to CDC estimates.
COVID variant JN.1 now more than 90% of cases in U.S., CDC ...Feb 5, 2024 ... Close to all new COVID-19 cases in the United States are now being caused by the JN.1 variant, the Centers for Disease Control and ...
COVID-19 Variant JN.1 is on the Rise. Here's What to Know. | Novel ...Dec 20, 2023 ... COVID-19 Variant JN.1 is on the Rise. Here's What to Know. ... The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the ...
COVID-19 Variant JN.1 is on the Rise. Here's What to Know. | UC ...Dec 20, 2023 ... The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on ...
New COVID Variant JN.1 Could Disrupt Holiday PlansDec 7, 2023 ... The good news is recent research suggests the 2023-2024 COVID-19 vaccine appears to work against this newest variant. But so few people have ...
COVID and flu surge could strain hospitals as JN.1 variant grows ...Dec 15, 2023 ... "COVID-19 hospitalizations are rising quickly," the CDC said, and the new variant JN.1 is making up an increasing share of cases.
JN.1 Omicron subvariant: Questions patients may have | American ...Dec 19, 2023 ... ... COVID-19 variant is JN ... symptoms across COVID-19 variants. The ... COVID-19 also helps protect against reinfection, severity and duration of ...
The JN.1 COVID Variant: Symptoms, Incubation Period and When to ...Jan 11, 2024 ... They might be mild or feel more severe. But if you're experiencing any of these, take a COVID-19 test (more on this below). What are the current ...
JN.1 COVID Variant Symptoms vs. Allergy SymptomsApr 22, 2024 ... Data currently suggest that COVID-19 severity indicators, including hospitalizations and deaths, are on the decline right now. But knowing if ...
Covid-19 variant JN.1 is now the leading cause of infections in the ...Dec 24, 2023 ... I have covid now. My symptoms are severe congestion and dry cough. Day 3, not much improved. Edit: forgot the most annoying symptom, loss of ...
Covid symptoms caused by JN.1 variant: What to know as cases riseDec 22, 2023 ... The JN.1 variant appears more transmissible than other strains but likely doesn't cause more severe Covid.
Global spread of COVID-19's JN.1 variant: Implications and public ...Feb 5, 2024 ... Unlike its close relative BA.2.86, JN.1 possesses a unique mutation in its spike protein, crucial in the virus's ability to infect human cells ...
What Is JN.1, the Latest COVID Variant? | The Transmission ...Nov 8, 2023 ... Infectious disease experts on what it is, signs, symptoms, and if you should be worried. SARS-CoV-2, the virus that causes COVID-19, is mutating ...
What to Know About the JN.1 Variant of the COVID-19 VirusDec 19, 2023 ... 1 was first detected in the U.S. in September but spread slowly at first. In recent weeks, however, it has accounted for a growing percentage of ...
JN.1 variant in enduring COVID-19 pandemic: is it a variety of ...Apr 17, 2024 ... JN.1 poses a unique challenge as one of the most immune-evading variants, with potential implications for COVID-19 transmission. The study ...
Emergence and spread of JN.1 COVID-19 variant | Bulletin of the ...Mar 5, 2024 ... The COVID-19 pandemic continues to significantly impact global health, economics, and public well-being. Millions suffer from long-term ...
WHO COVID vaccine advisers recommend switch to JN.1 strain ...Apr 29, 2024 ... Current vaccine might be less effective as JN.1 evolves. "There are further reductions in cross neutralization of JN.1 variants with F456L and/ ...
Effectiveness of the 2023-2024 Formulation of the Coronavirus ...Apr 29, 2024 ... Summary Among 47561 working-aged Cleveland Clinic employees, the 2023-2024 formula COVID-19 vaccine was 23% effective against the JN.1 lineage ...
Will COVID Vaccines Continue to Work Against JN.1 and Other New ...Jan 31, 2024 ... 1 is another Omicron variant closely related to BA.2.86, a subvariant that demonstrated the most recent large shift in SARS-CoV-2 evolution; JN.
COVID-19 Vaccine Effectiveness | NCIRD | CDCFeb 1, 2024 ... 1, a new variant that has become dominant in recent weeks. The virus that causes COVID-19 will continue to evolve. For viruses to survive they ...
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5 ...Feb 1, 2024 ... 1 and other BA.2.86 lineages.¶ Vaccine effectiveness (VE) of receipt of updated COVID-19 vaccine in preventing symptomatic SARS-CoV-2 infection ...
Virological characteristics of the SARS-CoV-2 JN.1 variant - The ...Jan 3, 2024 ... Compared with XBB and BA.2, BA.2.86 carries more than 30 mutations in the spike protein, indicating a high potential for immune evasion.
Virological characteristics of the SARS-CoV-2 JN.1 variant | bioRxivDec 9, 2023 ... 3 and other “FLip” variants carry S:L455F, which contributes to increased transmissibility and immune escape ability compared to the parental EG ...
1 Executive Summary Initial Risk Evaluation of JN.1, 19 December ...Dec 19, 2023 ... Therefore, the spread of this variant will unlikely increase the burden on national public health systems compared to other Omicron sublineages.
Comparison of Clinical Characteristics of Children Infected With ...Jun 1, 2023 ... ... Characteristics of Children Infected With Coronavirus Disease 2019 Between Omicron Variant BA.5 and BA.1/BA.2 in Japan ... Tatsuki Ikuse , Yuta ...
SARS-CoV-2 Variant Classifications and DefinitionsSep 1, 2023 ... ... differences in biology or circulation. ... In addition to the possible attributes of a ... 1 variant. BioRxiv 2021. DOI: https://doi.org/10.1101 ...
JN.1 Lineage ReportOutbreak.info explores COVID-19 and SARS-CoV-2 data with variant surveillance reports, data on cases and deaths, and a searchable research library.
Understanding the virological properties of SARS-CoV-2 variant JN.1Feb 9, 2024 ... 1 compared to other variants, including BA. ... 1 variant's distinct characteristics ... Virological characteristics of the SARS-CoV-2 JN.
根據最新資訊顯示，新冠肺炎JN.1變異株在全球範圍內仍然引起關注。根據美國疾病管制與預防中心（CDC）的數據顯示，JN.1變異株在美國占COVID-19確診案例的絕大多數，幾乎佔所有新確診案例的90% 14。同時，根據約翰霍普金斯大學的研究，JN.1的感染期可能持續五天或更長 2。此變異株已被世界衛生組織（WHO）指定為關注變異株 11。
JN.1變異株的症狀通常包括咽喉痛、噁心和腹瀉，並且可能出現少數患者會有嗅覺丧失等症狀 6。疫苗專家建議更新疫苗來針對這一新變異株，以維持對疾病的保護 4。目前可用的疫苗、檢測和治療對JN.1仍然有效 9。
考慮到JN.1變異株在全球範圍內快速傳播的情況，建議大眾繼續保持警惕，採取常見的防護措施，如佩戴口罩、保持社交距離和勤洗手。同時，及時接種疫苗也是預防感染的重要措施。為了有效控制病毒的傳播，密切關注當地衛生部門和醫療機構的指引和建議也至關重要。希望這些資訊能幫助您對JN.1變異株的最新情況有更清晰的了解。
JN.1 variant symptoms and severity overview
根據最新資訊，JN.1變異株是目前引起COVID-19感染的主要原因之一。這個變異株傳播速度較快，但可能並不會導致比其他變異株更嚴重的COVID-19症狀 23。但是，病患可能會出現一些常見的症狀，例如嚴重充血和乾咳 22。
JN.1變異株的症狀和潛伏期
JN.1變異株引起的症狀可能輕微或較為嚴重。如果您出現這些症狀，應當盡快進行COVID-19測試，以確定是否感染了病毒 20。此外，相關資料顯示，COVID-19的嚴重指標，如住院和死亡率，目前呈下降趨勢 21。
預防和保護措施
雖然JN.1變異株在傳播速度上較快，但是接種COVID-19疫苗仍然是預防感染的有效途徑。COVID-19疫苗不僅能保護免受病毒感染，還有助於降低感染後的嚴重性和持續時間 19。
綜合以上資訊，對於患有新冠肺炎JN.1變異株的病患，應密切關注症狀並盡早進行確診。同時，遵循公共衞生指引，保持良好的個人衛生習慣，接種疫苗是保護自己和他人免受感染的重要措施。 19 20 21 22 23。
How does the JN.1 variant impact COVID-19 transmission rates?
The JN.1 variant of COVID-19 has significant implications for transmission rates. This variant is characterized by unique mutations that affect its ability to infect human cells 24. Infectious disease experts have raised concerns about JN.1 being one of the most immune-evading variants, potentially leading to increased transmission rates 27.
Spread and Detection
The JN.1 variant was first detected in the U.S. in September and initially spread slowly. However, in recent weeks, it has accounted for a growing percentage of cases, indicating its increased transmissibility 26.
Impact on the Pandemic
The emergence and spread of the JN.1 variant continue to impact the ongoing COVID-19 pandemic globally. This variant poses challenges due to its unique features and potential implications for transmission 28.
Concerns and Recommendations
Given the characteristics of the JN.1 variant, it is important for public health authorities to closely monitor its spread and impact. Vaccination and adherence to public health guidelines remain crucial in mitigating the spread of COVID-19 variants, including JN.1 25.
In summary, the JN.1 variant's unique mutations and immune-evading properties contribute to its impact on COVID-19 transmission rates. Monitoring the spread of this variant and implementing appropriate public health measures are essential in controlling its further dissemination and curbing the pandemic.
Are current COVID-19 vaccines effective against the JN.1 variant?
目前有一些研究指出，2023-2024年的COVID-19疫苗對JN.1變異株的效力可能有所降低。例如，根據一份研究報告 30，在47561名工作年齡的Cleveland Clinic員工中，這一時期的疫苗對JN.1系統僅有23%的效力。同時，根據CDC的報告 32，COVID-19病毒持續演變，新變體JN.1近期已成為主要變異株之一，因此現有疫苗的效力可能受到影響。
JN.1變異株與其他變異株的關係
JN.1變異株與BA.2.86等其他變異株之間存在密切關係。根據一份報告 31，JN.1是另一種接近於BA.2.86的奧密克戎變異株，而BA.2.86是一個最近演變出現較大變化的小變異株。因此，具有JN.1變異株相關性的新奧密克戎變異株可能導致疫苗效力下降。
專家建議
鑑於JN.1變異株的出現，專家建議對COVID-19疫苗進行更新，以提高對新變異株的保護能力。根據一份報告 33，及早接種2023-2024年更新版本的COVID-19疫苗對預防JN.1及其他變異株引起的症狀性SARS-CoV-2感染效果顯著。
因此，雖然現有COVID-19疫苗對JN.1變異株的效力可能有所下降，但及早接種最新疫苗版本能提高對JN.1及其他新變異株的保護效果。建議密切關注疫苗更新情況，積極接種最新版本的COVID-19疫苗。
What are the key characteristics of the JN.1 variant compared to other COVID-19 strains?
新冠肺炎JN.1變異株最新情況顯示，這個變異株具有一些獨特的特徵與其他COVID-19變異株有所不同。根據WHO的一份風險評估報告，JN.1變異株與其他Omicron亞系相比，對國家公共衛生系統的負擔增加幅度較小，因此傳播的可能性較低 36。然而，這種變異株擁有的特定基因突變也使得它具有潛在的免疫逃逸能力 34 35。
研究指出，JN.1變異株在尖刺蛋白中携帶了超過30個突變，這表明了其對免疫的逃避能力 34。另外，該變異株的基因變異還包括S:L455F，這可能導致增加的傳播性和免疫逃逸能力 35。相比之下，JN.1變異株相對於其他變異株在病毒學特徵上表現出獨特性，這也使得科學家更關注其對公共衛生的影響。
因此，個人和社區應當對JN.1變異株保持警惕，採取適當的預防措施，包括戴口罩、保持社交距離和接種疫苗，以確保健康與安全。及時密切關注有關該變異株的最新研究和指引，將有助於應對可能帶來的健康挑戰。
Share
Copy
7
變異株JN.1具免疫脫逃性疫情傳播升溫. Yahoo奇摩（即時新聞）. 2023年12月19日. 衛福部疾管署今天公布國內12日至18日新增258例新冠肺炎本土確定病例（併發症），較前 ...
tw.news.yahoo.com